Full Name
Mei-Kim Ang
 
 
Email
gmsangmk@nus.edu.sg
 

Publications

Refined By:
Author:  Tan, Daniel SW
Author:  Kanesvaran, Ravindran

Results 1-6 of 6 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
1Dec-2022A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCLai, Gillianne GY ; Yeo, Jia Chi; Jain, Amit ; Zhou, Siqin ; Pang, Mengyuan; Alvarez, Jacob JS; Sim, Ngak Leng; Tan, Aaron C ; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie PL ; Rohatgi, Neha; Yeong, Joe PS; Takano, Angela ; Lim, Kiat Hon ; Gogna, Apoorva ; Too, Chow Wei ; Da Zhuang, Kun ; Tan, Wan Ling ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Wang, Lanying; Toh, Chee Keong ; Lim, Wan-Teck ; Tam, Wai Leong ; Tan, Sze Huey ; Skanderup, Anders MJ ; Tan, Eng-Huat ; Tan, Daniel SW 
22015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
33-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
424-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
51-Nov-2021Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesChua, Khi Pin; Teng, Yvonne HF ; Tan, Aaron C ; Takano, Angela ; Alvarez, Jacob JS; Nahar, Rahul; Rohatgi, Neha; Lai, Gillianne GY ; Aung, Zaw Win; Yeong, Joe PS; Lim, Kiat Hon ; Naeini, Marjan Mojtabavi; Kassam, Irfahan ; Jain, Amit ; Tan, Wan Ling ; Gogna, Apoorva ; Too, Chow Wei ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Anantham, Devanand ; Phua, Ghee Chee ; Tan, Bien Soo ; Lee, Yin Yeng; Wang, Lanying; Teo, Audrey SM; Khng, Alexis Jiaying; Lim, Ming Jie ; Suteja, Lisda; Toh, Chee Keong ; Lim, Wan-Teck ; Iyer, N Gopalakrishna ; Tam, Wai Leong ; Tan, Eng-Huat ; Zhai, Weiwei; Hillmer, Axel M; Skanderup, Anders J ; Tan, Daniel SW 
6Apr-2023Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistanceMa, Jun ; Tan, Sze Huey ; Yin, Daniel Xing Cheng; Tran, Nguyen Tuan Anh ; San Tan, Gek ; Lai, Gillianne Geet Yi ; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Rajasekaran, Tanujaa ; Tan, Eng-Huat ; Lim, Tony Kiat Hon ; Tan, Daniel Shao-Weng ; Lim, Darren Wan-Teck ; Ng, Quan Sing ; Tan, Wan Ling